InsiderTrades

Form 4 for EVMN Evommune, Inc.

Accepted 2025-11-12 00:00:00 ET · period of report 2025-11-07 · accession 0001876264-25-000006 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-11-12 2025-11-07 EVMN LSP 7 Cooperative UA 10% C - Cnv Deriv — +3.37M 3.37M New —
D 2025-11-12 2025-11-07 EVMN LSP 7 Cooperative UA 10% P - Purchase $16.00 +1.56M 4.93M +46% +$25.00M
DM 2025-11-12 2025-11-07 EVMN LSP 7 Cooperative UA 10% C - Cnv Deriv — -27.17M 0 -100% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-11-07 C A 3,367,133 — 3,367,133 D — — (F1) Each share of Series A Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration on a 1-for-7.9557 basis and had no expiration date. (F2) Each share of Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's IPO for no additional consideration on a 1-for-7.8721 basis and had no expiration date. (F3) Each share of Series C Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's IPO for no additional consideration on a 1-for-8.518 basis and had no expiration date. (F4) The securities are directly held by LSP 7 Cooperatief U.A., of which, LSP 7 Management B.V. is the sole director. The managing directors of LSP 7 Management B.V. are Martijn Kleijwegt, Rene Kuijten and Joachim Rothe.
2 Common Common Stock 2025-11-07 P A 1,562,500 $16.00 4,929,633 D — — (F4) The securities are directly held by LSP 7 Cooperatief U.A., of which, LSP 7 Management B.V. is the sole director. The managing directors of LSP 7 Management B.V. are Martijn Kleijwegt, Rene Kuijten and Joachim Rothe.
3 Derivative Series B Preferred Stock 2025-11-07 C D 5,090,000 — 0 D — · — to — 646,587 Common Stock (F2) Each share of Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's IPO for no additional consideration on a 1-for-7.8721 basis and had no expiration date. (F4) The securities are directly held by LSP 7 Cooperatief U.A., of which, LSP 7 Management B.V. is the sole director. The managing directors of LSP 7 Management B.V. are Martijn Kleijwegt, Rene Kuijten and Joachim Rothe.
4 Derivative Series A Preferred Stock 2025-11-07 C D 15,493,466 — 0 D — · — to — 1,947,477 Common Stock (F1) Each share of Series A Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration on a 1-for-7.9557 basis and had no expiration date. (F4) The securities are directly held by LSP 7 Cooperatief U.A., of which, LSP 7 Management B.V. is the sole director. The managing directors of LSP 7 Management B.V. are Martijn Kleijwegt, Rene Kuijten and Joachim Rothe.
5 Derivative Series C Preferred Stock 2025-11-07 C D 6,585,011 — 0 D — · — to — 773,069 Common Stock (F3) Each share of Series C Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's IPO for no additional consideration on a 1-for-8.518 basis and had no expiration date. (F4) The securities are directly held by LSP 7 Cooperatief U.A., of which, LSP 7 Management B.V. is the sole director. The managing directors of LSP 7 Management B.V. are Martijn Kleijwegt, Rene Kuijten and Joachim Rothe.